Hair loss affects both men and women worldwide. Many products claim to prevent hair loss, including hair masks, special shampoos, and daily routines. However, scientific evidence shows that cosmetic treatments alone cannot regenerate hair follicles. Effective hair loss treatment requires medically proven interventions tailored to the individual.

Scientific Basis of Hair Loss

• Androgenetic alopecia: The most common type of hair loss in both genders.

• DHT (dihydrotestosterone): A hormone derived from testosterone that causes follicle miniaturization and progressive hair thinning.

• Genetic factors: Hair loss risk is influenced by inherited genes from both parents.

While hair masks, shampoos, and routines may support scalp and hair health, they cannot stimulate new hair growth.

Evidence-Based Medical Treatments

Topical Minoxidil

• Applied 1–2 times daily on the scalp.

• Studies show a 15–20% increase in hair density after 6 months.

• Stimulates dormant follicles but does not create new follicles.

Finasteride

• 1 mg per day orally.

• Inhibits 5-alpha-reductase, reducing DHT production by up to 70%.

• Slows hair loss and preserves existing follicles.

PRP (Platelet-Rich Plasma)

• Monthly injections for 3–4 months.

• Growth factors in PRP stimulate follicle activity and improve density.

• Effective in early stages of androgenetic alopecia.

Hair Transplant

• Techniques: FUE or FUT.

• Provides a permanent solution in advanced hair loss with natural results.

• Recommended when conservative treatments are insufficient.

No shampoo, hair mask, or daily routine alone can replace these medically proven treatments.

Role of Healthy Habits

• Balanced diet, adequate sleep, and stress management support hair health.

• Hair care routines may reduce mechanical damage but cannot reverse follicle miniaturization.

Conclusion

• Hair masks, special shampoos, and routines support hair health but cannot prevent follicle loss or promote regrowth.

• Early, scientifically proven hair loss treatment is essential to slow or stop progression.

• Delaying proper intervention or relying solely on cosmetic routines may worsen hair loss.

References

1. Gentile, P., et al. (2023). Randomized controlled trial comparing PRP and 5% topical minoxidil in androgenetic alopecia. PubMed. Link

2. Gupta, M., et al. (2023). Meta-analysis of PRP and minoxidil combination therapy for AGA. PubMed. Link

3. Kaya, T., & Ertürk, S. (2022). Finasteride as a 5-alpha-reductase inhibitor: Mechanisms and clinical efficacy. Journal of Dermatological Treatment Online. Link

4. Liu, Y., et al. (2023). Network meta-analysis comparing finasteride, minoxidil, and combination therapy for AGA. PubMed. Link

5. Kaufman, K. D., et al. (2003). Long-term efficacy and safety of finasteride in male pattern hair loss. PubMed. Link

6. Rajput, R., et al. (2017). Molecular biology of androgenetic alopecia: AR gene mutations and hormonal influences. International Journal of Molecular Biology & Oncology. Link

7. Yıldız, H., & Altunay, I. (2020). Androgenetic alopecia: Clinical perspectives. DergiPark. Link

8. El Taieb, M., et al. (2023). Efficacy of oral vs topical minoxidil and PRP combination in AGA. PubMed. Link

9. Mapar, M., et al. (2019). PRP vs topical minoxidil in female pattern hair loss: Pilot clinical trial. PubMed. Link